{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T01:43:23Z","timestamp":1793497403161,"version":"4.5.0"},"reference-count":78,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,3,15]],"date-time":"2023-03-15T00:00:00Z","timestamp":1678838400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,3,15]],"date-time":"2023-03-15T00:00:00Z","timestamp":1678838400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lipids Health Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Lipid accumulation product (LAP) is an index calculated by waist circumference (WC) and triglyceride (TG), which reflects lipid toxicity. This study aims to investigate the association between the LAP index and nonalcoholic fatty liver disease (NAFLD) in a systematic review and meta-analysis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods and results<\/jats:title>\n                <jats:p>PubMed, Scopus, and Web of Science online databases were searched for eligible studies that investigated the association of the LAP index and NAFLD. Sixteen observational studies with 96,101 participants, including four cohort studies, one case\u2012control study and 11 cross-sectional studies with baseline data, were entered into this analysis. Fourteen studies reported a significant association between the LAP index and NAFLD, and two reported that this relation was not significant; two different meta-analyses (1- mean difference (MD) and 2- bivariate diagnostic test accuracy [DTA]) were conducted using Stata version 14. The LAP index was compared in subjects with and without NAFLD, and the difference was significant with 34.90 units (CI 95: 30.59\u201339.31, <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001) of the LAP index. The DTA meta-analysis was conducted and showed that the LAP index pooled sensitivity and specificity for screening of NAFLD were 94% (CI95: 72%\u201399%, I<jats:sup>2<\/jats:sup>\u2009=\u200999%, <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001) and 85% (CI95: 62%\u201396%, I<jats:sup>2<\/jats:sup>\u2009=\u200999%, <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001), respectively.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>The LAP Index is an inexpensive, sensitive, and specific method to evaluate NAFLD and may be valuable for NAFLD screening.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12944-023-01802-6","type":"journal-article","created":{"date-parts":[[2023,3,26]],"date-time":"2023-03-26T20:34:01Z","timestamp":1679862841000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":125,"title":["Lipid accumulation product (LAP) index for the diagnosis of nonalcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis"],"prefix":"10.1186","volume":"22","author":[{"given":"Menooa","family":"Ebrahimi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed Arsalan","family":"Seyedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed Ali","family":"Nabipoorashrafi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soghra","family":"Rabizadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mojdeh","family":"Sarzaeim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amirhossein","family":"Yadegar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Mohammadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Razman Arabzadeh","family":"Bahri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peyman","family":"Pakravan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paria","family":"Shafiekhani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manouchehr","family":"Nakhjavani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alireza","family":"Esteghamati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,15]]},"reference":[{"key":"1802_CR1","first-page":"e18201","volume":"13","author":"S Yaqub","year":"2021","unstructured":"Yaqub S, Ananias P, Shah A, Luenam K, Jose AM, Melo JP, et al. Decoding the pathophysiology of non-alcoholic fatty liver disease progressing to non-alcoholic steatohepatitis: a systematic review. Cureus. 2021;13:e18201.","journal-title":"Cureus."},{"key":"1802_CR2","doi-asserted-by":"publisher","first-page":"38605","DOI":"10.1038\/srep38605","volume":"6","author":"C-Q Liu","year":"2016","unstructured":"Liu C-Q, He C-M, Chen N, Wang D, Shi X, Liu Y, et al. Serum uric acid is independently and linearly associated with risk of nonalcoholic fatty liver disease in obese Chinese adults. Sci Rep. 2016;6:38605.","journal-title":"Sci Rep"},{"key":"1802_CR3","doi-asserted-by":"publisher","first-page":"e042843","DOI":"10.1136\/bmjopen-2020-042843","volume":"11","author":"X Zhang","year":"2021","unstructured":"Zhang X, Wu M, Liu Z, Yuan H, Wu X, Shi T, et al. Increasing prevalence of NAFLD\/NASH among children, adolescents and young adults from 1990 to 2017: a population-based observational study. BMJ Open. 2021;11:e042843.","journal-title":"BMJ Open"},{"key":"1802_CR4","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1111\/jgh.15009","volume":"35","author":"LA Adams","year":"2020","unstructured":"Adams LA, Roberts SK, Strasser SI, Mahady SE, Powell E, Estes C, et al. Nonalcoholic fatty liver disease burden: Australia, 2019\u20132030. J Gastroenterol Hepatol. 2020;35:1628\u201335.","journal-title":"J Gastroenterol Hepatol"},{"key":"1802_CR5","first-page":"1007","volume":"46","author":"P Mirmiran","year":"2017","unstructured":"Mirmiran P, Amirhamidi Z, Ejtahed H-S, Bahadoran Z, Azizi F. Relationship between diet and non-alcoholic fatty liver disease: a review article. Iran J Public Health. 2017;46:1007\u201317.","journal-title":"Iran J Public Health"},{"key":"1802_CR6","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1002\/cld.81","volume":"1","author":"P Puri","year":"2012","unstructured":"Puri P, Sanyal AJ. Nonalcoholic fatty liver disease: definitions, risk factors, and workup. Clin Liver Dis (Hoboken). 2012;1:99\u2013103.","journal-title":"Clin Liver Dis (Hoboken)"},{"key":"1802_CR7","first-page":"76","volume":"8","author":"R Kumar","year":"2020","unstructured":"Kumar R, Priyadarshi RN, Anand U. Non-alcoholic fatty liver disease: growing burden, adverse outcomes and associations. J Clin Transl Hepatol. 2020;8:76\u201386.","journal-title":"J Clin Transl Hepatol"},{"key":"1802_CR8","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1053\/j.gastro.2005.05.041","volume":"129","author":"CP Day","year":"2005","unstructured":"Day CP. Natural history of NAFLD: remarkably benign in the absence of cirrhosis. Gastroenterology. 2005;129:375\u20138.","journal-title":"Gastroenterology"},{"key":"1802_CR9","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1002\/hep.21327","volume":"44","author":"M Ekstedt","year":"2006","unstructured":"Ekstedt M, Franz\u00e9n LE, Mathiesen UL, Thorelius L, Holmqvist M, Bodemar G, et al. Long-term follow-up of patients with NAFLD and elevated liver enzymes. Hepatology. 2006;44:865\u201373.","journal-title":"Hepatology"},{"key":"1802_CR10","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1136\/gut.2009.205088","volume":"59","author":"VW-S Wong","year":"2010","unstructured":"Wong VW-S, Wong GL-H, Choi PC-L, Chan AW-H, Li MK-P, Chan H-Y, et al. Disease progression of non-alcoholic fatty liver disease: a prospective study with paired liver biopsies at 3 years. Gut. 2010;59:969\u201374.","journal-title":"Gut"},{"key":"1802_CR11","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1146\/annurev-pathol-020117-043617","volume":"13","author":"JP Arab","year":"2018","unstructured":"Arab JP, Arrese M, Trauner M. Recent insights into the pathogenesis of nonalcoholic fatty liver disease. Ann Rev Pathol: Mech of Dis. 2018;13:321\u201350.","journal-title":"Ann Rev Pathol: Mech of Dis"},{"key":"1802_CR12","doi-asserted-by":"publisher","first-page":"175628482110628","DOI":"10.1177\/17562848211062807","volume":"14","author":"P Decharatanachart","year":"2021","unstructured":"Decharatanachart P, Chaiteerakij R, Tiyarattanachai T, Treeprasertsuk S. Application of artificial intelligence in non-alcoholic fatty liver disease and liver fibrosis: a systematic review and meta-analysis. Therap Adv Gastroenterol. 2021;14:175628482110628.","journal-title":"Therap Adv Gastroenterol"},{"key":"1802_CR13","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1053\/j.gastro.2009.06.005","volume":"137","author":"A Kotronen","year":"2009","unstructured":"Kotronen A, Peltonen M, Hakkarainen A, Sevastianova K, Bergholm R, Johansson LM, et al. Prediction of non-alcoholic fatty liver disease and liver fat using metabolic and genetic factors. Gastroenterology. 2009;137:865\u201372.","journal-title":"Gastroenterology"},{"key":"1802_CR14","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1053\/gast.2002.35354","volume":"123","author":"S Saadeh","year":"2002","unstructured":"Saadeh S, Younossi ZM, Remer EM, Gramlich T, Ong JP, Hurley M, et al. The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterology. 2002;123:745\u201350.","journal-title":"Gastroenterology"},{"key":"1802_CR15","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1002\/hep.29596","volume":"67","author":"MS Middleton","year":"2018","unstructured":"Middleton MS, van Natta ML, Heba ER, Alazraki A, Trout AT, Masand P, et al. Diagnostic accuracy of magnetic resonance imaging hepatic proton density fat fraction in pediatric nonalcoholic fatty liver disease. Hepatology. 2018;67:858\u201372.","journal-title":"Hepatology"},{"key":"1802_CR16","doi-asserted-by":"publisher","first-page":"732496","DOI":"10.3389\/fphar.2021.732496","volume":"12","author":"S Rezaei","year":"2021","unstructured":"Rezaei S, Tabrizi R, Nowrouzi-Sohrabi P, Jalali M, Shabani-Borujeni M, Modaresi S, et al. the effects of vitamin D supplementation on anthropometric and biochemical indices in patients with non-alcoholic fatty liver disease: a systematic review and meta-analysis. Front Pharmacol. 2021;12:732496.","journal-title":"Front Pharmacol."},{"key":"1802_CR17","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1016\/j.aohep.2020.09.006","volume":"19","author":"JP Arab","year":"2020","unstructured":"Arab JP, Dirchwolf M, \u00c1lvares-da-Silva MR, Barrera F, Ben\u00edtez C, Castellanos-Fernandez M, et al. Latin American association for the study of the liver (ALEH) practice guidance for the diagnosis and treatment of non-alcoholic fatty liver disease. Ann Hepatol. 2020;19:674\u201390.","journal-title":"Ann Hepatol"},{"key":"1802_CR18","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.3748\/wjg.v25.i9.1116","volume":"25","author":"P Deibert","year":"2019","unstructured":"Deibert P, Lazaro A, Schaffner D, Berg A, Koenig D, Kreisel W, et al. Comprehensive lifestyle intervention vs soy protein-based meal regimen in non-alcoholic steatohepatitis. World J Gastroenterol. 2019;25:1116\u201331.","journal-title":"World J Gastroenterol"},{"key":"1802_CR19","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1053\/j.gastro.2015.04.005","volume":"149","author":"E Vilar-Gomez","year":"2015","unstructured":"Vilar-Gomez E, Martinez-Perez Y, Calzadilla-Bertot L, Torres-Gonzalez A, Gra-Oramas B, Gonzalez-Fabian L, et al. Weight loss through lifestyle modification significantly reduces features of nonalcoholic steatohepatitis. Gastroenterology. 2015;149:367-378.e5.","journal-title":"Gastroenterology"},{"key":"1802_CR20","doi-asserted-by":"publisher","first-page":"8341","DOI":"10.3748\/wjg.v20.i26.8341","volume":"20","author":"M del Ben","year":"2014","unstructured":"del Ben M. Modern approach to the clinical management of non-alcoholic fatty liver disease. World J Gastroenterol. 2014;20:8341.","journal-title":"World J Gastroenterol"},{"key":"1802_CR21","doi-asserted-by":"publisher","first-page":"100192","DOI":"10.1016\/j.jhepr.2020.100192","volume":"2","author":"P Burra","year":"2020","unstructured":"Burra P, Becchetti C, Germani G. NAFLD and liver transplantation: disease burden, current management and future challenges. JHEP Rep. 2020;2:100192.","journal-title":"JHEP Rep"},{"key":"1802_CR22","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/s12944-021-01561-2","volume":"20","author":"G Sheng","year":"2021","unstructured":"Sheng G, Lu S, Xie Q, Peng N, Kuang M, Zou Y. The usefulness of obesity and lipid-related indices to predict the presence of Non-alcoholic fatty liver disease. Lipids Health Dis. 2021;20:134.","journal-title":"Lipids Health Dis"},{"key":"1802_CR23","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/1471-2261-5-26","volume":"5","author":"HS Kahn","year":"2005","unstructured":"Kahn HS. The \u201clipid accumulation product\u201d performs better than the body mass index for recognizing cardiovascular risk: a population-based comparison. BMC Cardiovasc Disord. 2005;5:26.","journal-title":"BMC Cardiovasc Disord"},{"key":"1802_CR24","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1016\/j.clnu.2016.12.020","volume":"36","author":"MV Nascimento-Ferreira","year":"2017","unstructured":"Nascimento-Ferreira MV, Rendo-Urteaga T, Vilanova-Campelo RC, Carvalho HB, da Paz OG, PaesLandim MB, et al. The lipid accumulation product is a powerful tool to predict metabolic syndrome in undiagnosed Brazilian adults. Clin Nutr. 2017;36:1693\u2013700.","journal-title":"Clin Nutr"},{"key":"1802_CR25","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1038\/ejcn.2012.83","volume":"66","author":"C Xia","year":"2012","unstructured":"Xia C, Li R, Zhang S, Gong L, Ren W, Wang Z, et al. Lipid accumulation product is a powerful index for recognizing insulin resistance in non-diabetic individuals. Eur J Clin Nutr. 2012;66:1035\u20138.","journal-title":"Eur J Clin Nutr"},{"key":"1802_CR26","doi-asserted-by":"publisher","first-page":"99","DOI":"10.34172\/mejdd.2020.168","volume":"12","author":"R Jamali","year":"2020","unstructured":"Jamali R, Ebrahimi M, Faryabi A, Ashraf H. Which metabolic index is appropriate for predicting non-alcoholic Steatohepatitis? Middle East J Dig Dis. 2020;12:99\u2013105.","journal-title":"Middle East J Dig Dis"},{"key":"1802_CR27","first-page":"99","volume":"22","author":"K Balankhe","year":"2021","unstructured":"Balankhe K, Nayak R, Kumar Modi R, Gupta PK, Jain P, Varshney AK, et al. Comparison of non-invasive scoring systems with ultrasound and liver elastography in predicting non-alcoholic fatty liver disease in healthy population. J, Ind Acad Clin Med. 2021;22:99\u2013103.","journal-title":"J, Ind Acad Clin Med"},{"key":"1802_CR28","first-page":"n71","volume":"2021","author":"MJ Page","year":"2020","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, The PRISMA, et al. statement: an updated guideline for reporting systematic reviews. BMJ. 2020;2021:n71.","journal-title":"BMJ"},{"key":"1802_CR29","unstructured":"Wells G, Shea B, O\u2019Connell D, Peterson J, Welch V, Losos M, Tugwell P. Newcastle-Ottawa quality assessment scale cohort studies. University of Ottawa;\u00a02014.\u00a0https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK99082\/bin\/appb-fm4.pdf."},{"key":"1802_CR30","doi-asserted-by":"crossref","unstructured":"HIGGINS, Julian PT, et al. (editors). Cochrane handbook for systematic reviews of interventions. Wiley; 2019.","DOI":"10.1002\/9781119536604"},{"key":"1802_CR31","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.2307\/2533446","volume":"50","author":"CB Begg","year":"1994","unstructured":"Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;50:1088.","journal-title":"Biometrics"},{"key":"1802_CR32","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","volume":"315","author":"M Egger","year":"1997","unstructured":"Egger M, Smith GD, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629\u201334.","journal-title":"BMJ"},{"key":"1802_CR33","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.21608\/ejhm.2022.224889","volume":"87","author":"M Kassem","year":"2022","unstructured":"Kassem M, Galal GM, Younis MAA, Zaghloul AM. Anthropometric measures as predictors of non-alcoholic fatty liver disease in adult asymptomatic Egyptians. Egypt J Hosp Med. 2022;87:1400\u20136.","journal-title":"Egypt J Hosp Med"},{"key":"1802_CR34","doi-asserted-by":"publisher","first-page":"831960","DOI":"10.3389\/fendo.2022.831960","volume":"13","author":"X Chen","year":"2022","unstructured":"Chen X, Shi F, Xiao J, Huang F, Cheng F, Wang L, et al. Associations between abdominal obesity indices and nonalcoholic fatty liver disease: Chinese visceral adiposity index. Front Endocrinol (Lausanne). 2022;13:831960.","journal-title":"Front Endocrinol (Lausanne)."},{"key":"1802_CR35","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1097\/MEG.0000000000002399","volume":"34","author":"L Zhang","year":"2022","unstructured":"Zhang L, Zhang M, Wang M, Wang M, Zhang R, Wang H, et al. External validation and comparison of simple tools to screen for nonalcoholic fatty liver disease in Chinese community population. Eur J Gastroenterol Hepatol. 2022;34:865\u201372.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"1802_CR36","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s12944-021-01617-3","volume":"21","author":"Y Liu","year":"2022","unstructured":"Liu Y, Wang W. Sex-specific contribution of lipid accumulation product and cardiometabolic index in the identification of nonalcoholic fatty liver disease among Chinese adults. Lipids Health Dis. 2022;21:8.","journal-title":"Lipids Health Dis"},{"key":"1802_CR37","first-page":"1","volume":"2021","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Li B, Liu N, Wang P, He J. Evaluation of different anthropometric indicators for screening for nonalcoholic fatty liver disease in elderly individuals. Int J Endocrinol. 2021;2021:1\u201312.","journal-title":"Int J Endocrinol"},{"key":"1802_CR38","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1590\/1806-9282.20210316","volume":"67","author":"NS Almeida","year":"2021","unstructured":"Almeida NS, Rocha R, Daltro C, de Souza CA, Silva RLPD, Sarno MAC, et al. Anthropometric clinical indicators of visceral adiposity as predictors of nonalcoholic fatty liver disease. Rev Assoc Med Bras. 2021;67:1544\u20139.","journal-title":"Rev Assoc Med Bras"},{"key":"1802_CR39","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.3390\/jcm10071507","volume":"10","author":"K Koz\u0142owska-Petriczko","year":"2021","unstructured":"Koz\u0142owska-Petriczko K, Wunsch E, Petriczko J, Syn W-K, Milkiewicz P. Diagnostic accuracy of non-imaging and ultrasound-based assessment of hepatic steatosis using Controlled Attenuation Parameter (CAP) as reference. J Clin Med. 2021;10:1507.","journal-title":"J Clin Med"},{"key":"1802_CR40","doi-asserted-by":"publisher","first-page":"857","DOI":"10.3390\/ijerph18030857","volume":"18","author":"I-T Lin","year":"2021","unstructured":"Lin I-T, Lee M-Y, Wang C-W, Wu D-W, Chen S-C. Gender differences in the relationships among metabolic syndrome and various obesity-related indices with nonalcoholic fatty liver disease in a Taiwanese population. Int J Environ Res Public Health. 2021;18:857.","journal-title":"Int J Environ Res Public Health"},{"key":"1802_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.maturitas.2018.06.013","volume":"116","author":"E Vassilatou","year":"2018","unstructured":"Vassilatou E, Lafoyianni S, Vassiliadi DA, Ioannidis D, Paschou SA, Mizamtsidi M, et al. Visceral adiposity index for the diagnosis of nonalcoholic fatty liver disease in premenopausal women with and without polycystic ovary syndrome. Maturitas. 2018;116:1\u20137.","journal-title":"Maturitas"},{"key":"1802_CR42","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1016\/j.cgh.2012.12.031","volume":"11","author":"EM Koehler","year":"2013","unstructured":"Koehler EM, Schouten JNL, Hansen BE, Hofman A, Stricker BH, Janssen HLA. External validation of the fatty liver index for identifying nonalcoholic fatty liver disease in a population-based Study. Clin Gastroenterol Hepatol. 2013;11:1201\u20134.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1802_CR43","first-page":"129","volume":"38","author":"S Duan","year":"2022","unstructured":"Duan S, Liu Z, Chen J, Yao S. Value of lipid accumulation product and visceral fat index in predicting nonalcoholic fatty liver disease. J Clin Hepatol. 2022;38:129\u201334.","journal-title":"J Clin Hepatol."},{"key":"1802_CR44","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1186\/s12916-014-0154-x","volume":"12","author":"C-L Cheung","year":"2014","unstructured":"Cheung C-L, Lam KS, Wong IC, Cheung BM. Non-invasive score identifies ultrasonography-diagnosed non-alcoholic fatty liver disease and predicts mortality in the USA. BMC Med. 2014;12:154.","journal-title":"BMC Med"},{"key":"1802_CR45","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s12986-017-0206-2","volume":"14","author":"H Dai","year":"2017","unstructured":"Dai H, Wang W, Chen R, Chen Z, Lu Y, Yuan H. Lipid accumulation product is a powerful tool to predict non-alcoholic fatty liver disease in Chinese adults. Nutr Metab (Lond). 2017;14:49.","journal-title":"Nutr Metab (Lond)"},{"key":"1802_CR46","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1111\/j.1751-2980.2010.00476.x","volume":"12","author":"JG Fan","year":"2011","unstructured":"Fan JG, Jia JD, Li YM, Wang BY, Lu LG, Shi JP, et al. Guidelines for the diagnosis and management of nonalcoholic fatty liver disease: update 2010. J Dig Dis. 2011;12:38\u201344.","journal-title":"J Dig Dis"},{"key":"1802_CR47","unstructured":"Macaskill P, Gatsonis C, Deeks J, Harbord R, Takwoingi Y. Cochrane handbook for systematic reviews of diagnostic test accuracy chapter 10 analysing and presenting results. 2010."},{"key":"1802_CR48","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1016\/j.metabol.2016.01.012","volume":"65","author":"Y Fazel","year":"2016","unstructured":"Fazel Y, Koenig AB, Sayiner M, Goodman ZD, Younossi ZM. Epidemiology and natural history of non-alcoholic fatty liver disease. Metabolism. 2016;65:1017\u201325.","journal-title":"Metabolism"},{"key":"1802_CR49","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/s00592-012-0406-1","volume":"50","author":"M Soresi","year":"2013","unstructured":"Soresi M, Noto D, Cefal\u00f9 AB, Martini S, Vigna GB, Fonda M, et al. Nonalcoholic fatty liver and metabolic syndrome in Italy: results from a multicentric study of the Italian Arteriosclerosis society. Acta Diabetol. 2013;50:241\u20139.","journal-title":"Acta Diabetol"},{"key":"1802_CR50","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.jhep.2012.12.005","volume":"58","author":"M Blachier","year":"2013","unstructured":"Blachier M, Leleu H, Peck-Radosavljevic M, Valla D-C, Roudot-Thoraval F. The burden of liver disease in Europe: a review of available epidemiological data. J Hepatol. 2013;58:593\u2013608.","journal-title":"J Hepatol"},{"key":"1802_CR51","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1002\/hep.20734","volume":"42","author":"G Bedogni","year":"2005","unstructured":"Bedogni G, Miglioli L, Masutti F, Tiribelli C, Marchesini G, Bellentani S. Prevalence of and risk factors for nonalcoholic fatty liver disease: The Dionysos nutrition and liver study. Hepatology. 2005;42:44\u201352.","journal-title":"Hepatology"},{"key":"1802_CR52","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1016\/S0168-8278(01)00192-1","volume":"35","author":"C Loguercio","year":"2001","unstructured":"Loguercio C, de Girolamo V, de Sio I, Tuccillo C, Ascione A, Baldi F, et al. Non-alcoholic fatty liver disease in an area of southern Italy: main clinical, histological, and pathophysiological aspects. J Hepatol. 2001;35:568\u201374.","journal-title":"J Hepatol"},{"key":"1802_CR53","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1053\/j.gastro.2010.09.038","volume":"140","author":"CD Williams","year":"2011","unstructured":"Williams CD, Stengel J, Asike MI, Torres DM, Shaw J, Contreras M, et al. Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study. Gastroenterology. 2011;140:124\u201331.","journal-title":"Gastroenterology"},{"key":"1802_CR54","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1093\/aje\/kws448","volume":"178","author":"M Lazo","year":"2013","unstructured":"Lazo M, Hernaez R, Eberhardt MS, Bonekamp S, Kamel I, Guallar E, et al. Prevalence of nonalcoholic fatty liver disease in the United States: the third national health and nutrition examination survey, 1988\u20131994. Am J Epidemiol. 2013;178:38\u201345.","journal-title":"Am J Epidemiol"},{"key":"1802_CR55","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1159\/000282081","volume":"28","author":"S Caldwell","year":"2010","unstructured":"Caldwell S, Argo C. The natural history of non-alcoholic fatty liver disease. Digest Dis. 2010;28:162\u20138.","journal-title":"Digest Dis"},{"key":"1802_CR56","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1111\/obr.12407","volume":"17","author":"L Li","year":"2016","unstructured":"Li L, Liu D-W, Yan H-Y, Wang Z-Y, Zhao S-H, Wang B. Obesity is an independent risk factor for non-alcoholic fatty liver disease: evidence from a meta-analysis of 21 cohort studies. Obes Rev. 2016;17:510\u20139.","journal-title":"Obes Rev"},{"key":"1802_CR57","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1002\/hep.26390","volume":"58","author":"RM Kwok","year":"2013","unstructured":"Kwok RM, Torres DM, Harrison SA. Vitamin D and nonalcoholic fatty liver disease (NAFLD): Is it more than just an association? Hepatology. 2013;58:1166\u201374.","journal-title":"Hepatology"},{"key":"1802_CR58","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1002\/hep4.1935","volume":"6","author":"M Noureddin","year":"2022","unstructured":"Noureddin M, Ntanios F, Malhotra D, Hoover K, Emir B, McLeod E, et al. Predicting NAFLD prevalence in the United States using national health and nutrition examination Survey 2017\u20132018 transient elastography data and application of machine learning. Hepatol Commun. 2022;6:1537\u201348.","journal-title":"Hepatol Commun"},{"key":"1802_CR59","doi-asserted-by":"publisher","first-page":"5803","DOI":"10.3748\/wjg.v27.i35.5803","volume":"27","author":"CG Dietrich","year":"2021","unstructured":"Dietrich CG, Rau M, Geier A. Screening for nonalcoholic fatty liver disease-when, who and how? World J Gastroenterol. 2021;27:5803\u201321.","journal-title":"World J Gastroenterol"},{"key":"1802_CR60","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.2147\/CIA.S330313","volume":"16","author":"S Zhao","year":"2021","unstructured":"Zhao S, Ren Z, Yu S, Chi C, Tang J, Maimaitiaili R, et al. Association between lipid accumulation product and target organ damage in elderly population: the Northern Shanghai study. Clin Interv Aging. 2021;16:1769\u201376.","journal-title":"Clin Interv Aging"},{"key":"1802_CR61","doi-asserted-by":"publisher","first-page":"831960","DOI":"10.3389\/fendo.2022.831960","volume":"13","author":"X Chen","year":"2022","unstructured":"Chen X, Shi F, Xiao J, Huang F, Cheng F, Wang L, et al. Associations between abdominal obesity indices and nonalcoholic fatty liver disease: Chinese visceral adiposity index. Front Endocrinol (Lausanne). 2022;13:831960.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1802_CR62","doi-asserted-by":"publisher","first-page":"633","DOI":"10.3892\/br.2014.309","volume":"2","author":"M Tomizawa","year":"2014","unstructured":"Tomizawa M, Kawanabe Y, Shinozaki F, Sato S, Motoyoshi Y, Sugiyama T, et al. Triglyceride is strongly associated with nonalcoholic fatty liver disease among markers of hyperlipidemia and diabetes. Biomed Rep. 2014;2:633\u20136.","journal-title":"Biomed Rep"},{"key":"1802_CR63","doi-asserted-by":"publisher","first-page":"3570","DOI":"10.3390\/ijms21103570","volume":"21","author":"K Zorena","year":"2020","unstructured":"Zorena K, Jachimowicz-Duda O, \u015al\u0119zak D, Robakowska M, Mrugacz M. Adipokines and obesity Potential link to metabolic disorders and chronic complications. Int J Mol Sci. 2020;21:3570.","journal-title":"Int J Mol Sci"},{"key":"1802_CR64","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.jhep.2005.11.030","volume":"44","author":"CZ Larter","year":"2006","unstructured":"Larter CZ, Farrell GC. Insulin resistance, adiponectin, cytokines in NASH: Which is the best target to treat? J Hepatol. 2006;44:253\u201361.","journal-title":"J Hepatol"},{"key":"1802_CR65","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1038\/nri1937","volume":"6","author":"H Tilg","year":"2006","unstructured":"Tilg H, Moschen AR. Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat Rev Immunol. 2006;6:772\u201383.","journal-title":"Nat Rev Immunol"},{"key":"1802_CR66","doi-asserted-by":"publisher","first-page":"e14744","DOI":"10.1111\/ijcp.14744","volume":"75","author":"V Musazadeh","year":"2021","unstructured":"Musazadeh V, Dehghan P, Saleh-Ghadimi S, Abbasalizad FM. Omega 3-rich Camelina sativa oil in the context of a weight loss program improves glucose homeostasis, inflammation and oxidative stress in patients with NAFLD: a randomised placebo-controlled clinical trial. Int J Clin Pract. 2021;75:e14744.","journal-title":"Int J Clin Pract"},{"key":"1802_CR67","doi-asserted-by":"publisher","first-page":"844242","DOI":"10.3389\/fnut.2022.844242","volume":"9","author":"V Musazadeh","year":"2022","unstructured":"Musazadeh V, Roshanravan N, Dehghan P, Ahrabi SS. Effect of probiotics on liver enzymes in patients with non-alcoholic fatty liver disease: an umbrella of systematic review and meta-analysis. Front Nutr. 2022;9:844242.","journal-title":"Front Nutr."},{"key":"1802_CR68","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1097\/MEG.0000000000002297","volume":"34","author":"V Musazadeh","year":"2022","unstructured":"Musazadeh V, Dehghan P, Khoshbaten M. Efficacy of omega-3-rich Camelina sativa on the metabolic and clinical markers in nonalcoholic fatty liver disease: a randomized, controlled trial. Eur J Gastroenterol Hepatol. 2022;34:537\u201345.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"1802_CR69","doi-asserted-by":"publisher","first-page":"105074","DOI":"10.1016\/j.jff.2022.105074","volume":"92","author":"MA Farhangi","year":"2022","unstructured":"Farhangi MA, Dehghan P, Musazadeh V, Kavyani M, Maleki P. Effectiveness of omega-3 and prebiotics on adiponectin, leptin, liver enzymes lipid profile and anthropometric indices in patients with non-alcoholic fatty liver disease: a randomized controlled trial. J Funct Foods. 2022;92:105074.","journal-title":"J Funct Foods"},{"key":"1802_CR70","first-page":"622","volume":"13","author":"VJ Antraco","year":"2021","unstructured":"Antraco VJ, Hirata BKS, de Jesus Sim\u00e3o J, Cruz MM, da Silva VS, da Cunha de Sa RDC, et al. Omega-3 polyunsaturated fatty acids prevent nonalcoholic steatohepatitis (NASH) and stimulate Adipogenesis. Nutr. 2021;13:622.","journal-title":"Nutr"},{"key":"1802_CR71","doi-asserted-by":"publisher","first-page":"2677","DOI":"10.1016\/j.numecd.2022.07.024","volume":"32","author":"SA Nabipoorashrafi","year":"2022","unstructured":"Nabipoorashrafi SA, Seyedi SA, Rabizadeh S, Ebrahimi M, Ranjbar SA, Reyhan SK, et al. The accuracy of triglyceride-glucose (TyG) index for the screening of metabolic syndrome in adults: a systematic review and meta-analysis. Nutr, Metab Cardiovasc Dis. 2022;32:2677\u201388.","journal-title":"Nutr, Metab Cardiovasc Dis"},{"key":"1802_CR72","doi-asserted-by":"publisher","first-page":"030006052110499","DOI":"10.1177\/03000605211049960","volume":"49","author":"S Golabi","year":"2021","unstructured":"Golabi S, Ajloo S, Maghsoudi F, Adelipour M, Naghashpour M. Associations between traditional and non-traditional anthropometric indices and cardiometabolic risk factors among inpatients with type 2 diabetes mellitus: a cross-sectional study. J Int Med Res. 2021;49:030006052110499.","journal-title":"J Int Med Res"},{"key":"1802_CR73","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1530\/EJE-10-1039","volume":"164","author":"MJ Taverna","year":"2011","unstructured":"Taverna MJ, Mart\u00ednez-Larrad MT, Frechtel GD, Serrano-R\u00edos M. Lipid accumulation product: a powerful marker of metabolic syndrome in healthy population. Eur J Endocrinol. 2011;164:559\u201367.","journal-title":"Eur J Endocrinol"},{"issue":"Suppl 1","key":"1802_CR74","doi-asserted-by":"publisher","first-page":"S18","DOI":"10.1016\/S1665-2681(19)31822-8","volume":"8","author":"P Almeda-Vald\u00e9s","year":"2009","unstructured":"Almeda-Vald\u00e9s P, Cuevas-Ramos D, Aguilar-Salinas CA. Metabolic syndrome and non-alcoholic fatty liver disease. Ann Hepatol. 2009;8(Suppl 1):S18-24.","journal-title":"Ann Hepatol"},{"key":"1802_CR75","doi-asserted-by":"publisher","first-page":"760361","DOI":"10.3389\/fcvm.2021.760361","volume":"8","author":"Y Shi","year":"2022","unstructured":"Shi Y, Hu L, Li M, Zhou W, Wang T, Zhu L, et al. Relationship between the lipid accumulation product index and arterial stiffness in the Chinese population with hypertension: a report from the China H-type hypertension registry study. Front Cardiovasc Med. 2022;8:760361.","journal-title":"Front Cardiovasc Med"},{"key":"1802_CR76","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/j.atherosclerosis.2014.10.004","volume":"237","author":"M Sunbul","year":"2014","unstructured":"Sunbul M, Agirbasli M, Durmus E, Kivrak T, Akin H, Aydin Y, et al. Arterial stiffness in patients with non-alcoholic fatty liver disease is related to fibrosis stage and epicardial adipose tissue thickness. Atherosclerosis. 2014;237:490\u20133.","journal-title":"Atherosclerosis"},{"key":"1802_CR77","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/1471-2261-12-78","volume":"12","author":"J-K Chiang","year":"2012","unstructured":"Chiang J-K, Koo M. Lipid accumulation product: a simple and accurate index for predicting metabolic syndrome in Taiwanese people aged 50 and over. BMC Cardiovasc Disord. 2012;12:78.","journal-title":"BMC Cardiovasc Disord"},{"key":"1802_CR78","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1007\/s10396-020-01040-8","volume":"47","author":"M Yoneda","year":"2020","unstructured":"Yoneda M, Honda Y, Nogami A, Imajo K, Nakajima A. Advances in ultrasound elastography for nonalcoholic fatty liver disease. J Med Ultrason. 2020;47:521\u201333.","journal-title":"J Med Ultrason"}],"container-title":["Lipids in Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-023-01802-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12944-023-01802-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-023-01802-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,26]],"date-time":"2023-03-26T20:35:25Z","timestamp":1679862925000},"score":1,"resource":{"primary":{"URL":"https:\/\/lipidworld.biomedcentral.com\/articles\/10.1186\/s12944-023-01802-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,15]]},"references-count":78,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1802"],"URL":"https:\/\/doi.org\/10.1186\/s12944-023-01802-6","relation":{},"ISSN":["1476-511X"],"issn-type":[{"value":"1476-511X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,15]]},"assertion":[{"value":"20 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article does not contain any studies with human participants or animals performed by the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"41"}}